Regeneron Pharmaceuticals (REGN) Cash from Operations (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Cash from Operations came in at 1078900000.0 in Q1 2026, up 3.23% year-on-year from 1045100000.0 in Q1 2025, and down 7.84% quarter-over-quarter from 1170700000.0 in Q4 2025.
Regeneron Pharmaceuticals has reported Cash from Operations for 18 years, with the latest figure at 1078900000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 3.23% year-over-year to 1078900000.0; the trailing twelve-month figure through Mar 2026 stood at 5012700000.0 (up 26.8% YoY), and the FY2025 full-year result was 4978900000.0, up 12.63% from the prior year.
- Cash from Operations for Q1 2026 stood at 1078900000.0, down from 1170700000.0 in the prior quarter.
- The five-year high for Cash from Operations was 2101700000.0 in Q1 2022, with the low at 354000000.0 in Q2 2024.
- Average Cash from Operations over 5 years is 1181600000.0, with a median of 1144400000.0 recorded in 2025.
- Year-over-year, Cash from Operations tumbled 81.58% in 2022 and surged 223.28% in 2025.
- Tracing REGN's Cash from Operations over 5 years: stood at 1719900000.0 in 2022, then plunged by 36.64% to 1089700000.0 in 2023, then advanced by 15.89% to 1262800000.0 in 2024, then decreased by 7.29% to 1170700000.0 in 2025, then retreated by 7.84% to 1078900000.0 in 2026.
- The last three Cash from Operations figures came in at 1078900000.0 (Q1 2026), 1170700000.0 (Q4 2025), and 1618700000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -354.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Bn |
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.17 Bn |
| Dec 31, 2025 | 1.17 Bn |
| Sep 30, 2025 | 1.62 Bn |
| Sep 30, 2025 | 1.62 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.26 Bn |
| Dec 31, 2024 | 1.26 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 354.00 Mn |
| Jun 30, 2024 | 354.00 Mn |
| Mar 31, 2024 | 1.51 Bn |
| Mar 31, 2024 | 1.51 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 1.37 Bn |
| Mar 31, 2023 | 1.37 Bn |
| Dec 31, 2022 | 1.72 Bn |
| Dec 31, 2022 | 1.72 Bn |
| Sep 30, 2022 | 628.90 Mn |
| Sep 30, 2022 | 628.90 Mn |
| Jun 30, 2022 | 564.40 Mn |
| Jun 30, 2022 | 564.40 Mn |
| Mar 31, 2022 | 2.10 Bn |
| Mar 31, 2022 | 2.10 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Sep 30, 2021 | 3.41 Bn |
| Sep 30, 2021 | 3.41 Bn |
| Jun 30, 2021 | 626.70 Mn |
| Jun 30, 2021 | 626.70 Mn |
| Mar 31, 2021 | 668.50 Mn |
| Mar 31, 2021 | 668.50 Mn |
| Dec 31, 2020 | 1.23 Bn |
| Dec 31, 2020 | 1.23 Bn |
| Sep 30, 2020 | -254.30 Mn |
| Sep 30, 2020 | -254.30 Mn |
| Jun 30, 2020 | 943.40 Mn |
| Jun 30, 2020 | 943.40 Mn |
| Mar 31, 2020 | 698.00 Mn |
| Mar 31, 2020 | 698.00 Mn |
| Dec 31, 2019 | 787.40 Mn |
| Dec 31, 2019 | 787.40 Mn |
| Sep 30, 2019 | 557.30 Mn |
| Sep 30, 2019 | 557.30 Mn |
| Jun 30, 2019 | 188.30 Mn |
| Jun 30, 2019 | 188.30 Mn |
| Mar 31, 2019 | 897.00 Mn |
| Mar 31, 2019 | 897.00 Mn |
| Dec 31, 2018 | 728.80 Mn |
| Dec 31, 2018 | 728.80 Mn |
| Sep 30, 2018 | 452.90 Mn |
| Sep 30, 2018 | 452.90 Mn |
| Jun 30, 2018 | 394.60 Mn |
| Jun 30, 2018 | 394.60 Mn |
| Mar 31, 2018 | 618.80 Mn |
| Mar 31, 2018 | 618.80 Mn |
| Dec 31, 2017 | 566.94 Mn |
| Dec 31, 2017 | 566.94 Mn |
| Sep 30, 2017 | 414.83 Mn |
| Sep 30, 2017 | 414.83 Mn |
| Jun 30, 2017 | -30.57 Mn |
| Jun 30, 2017 | -30.57 Mn |
| Mar 31, 2017 | 355.90 Mn |
| Mar 31, 2017 | 355.90 Mn |
| Dec 31, 2016 | 390.38 Mn |
| Dec 31, 2016 | 390.38 Mn |
| Sep 30, 2016 | 651.03 Mn |
| Sep 30, 2016 | 651.03 Mn |
| Jun 30, 2016 | 399.50 Mn |
| Jun 30, 2016 | 399.50 Mn |
| Mar 31, 2016 | 44.99 Mn |
| Mar 31, 2016 | 44.99 Mn |
| Dec 31, 2015 | 281.82 Mn |
| Dec 31, 2015 | 281.82 Mn |
| Sep 30, 2015 | 892.85 Mn |
| Sep 30, 2015 | 892.85 Mn |
| Jun 30, 2015 | 257.83 Mn |
| Jun 30, 2015 | 257.83 Mn |
| Mar 31, 2015 | -101.73 Mn |
| Mar 31, 2015 | -101.73 Mn |
| Dec 31, 2014 | 198.18 Mn |
| Dec 31, 2014 | 198.18 Mn |
| Sep 30, 2014 | 164.32 Mn |
| Sep 30, 2014 | 164.32 Mn |
| Jun 30, 2014 | 336.41 Mn |
| Jun 30, 2014 | 336.41 Mn |
| Mar 31, 2014 | 53.53 Mn |
| Mar 31, 2014 | 53.53 Mn |
| Dec 31, 2013 | 281.73 Mn |
| Dec 31, 2013 | 281.73 Mn |
| Sep 30, 2013 | 92.46 Mn |
| Sep 30, 2013 | 92.46 Mn |
| Jun 30, 2013 | 128.16 Mn |
| Jun 30, 2013 | 128.16 Mn |
| Mar 31, 2013 | 86.25 Mn |
| Mar 31, 2013 | 86.25 Mn |
| Dec 31, 2012 | 93.19 Mn |
| Dec 31, 2012 | 93.19 Mn |
| Sep 30, 2012 | -2.38 Mn |
| Sep 30, 2012 | -2.38 Mn |
| Jun 30, 2012 | -78.38 Mn |
| Jun 30, 2012 | -78.38 Mn |
| Mar 31, 2012 | -87.04 Mn |
| Mar 31, 2012 | -87.04 Mn |
| Dec 31, 2011 | -50.32 Mn |
| Dec 31, 2011 | -50.32 Mn |
| Sep 30, 2011 | -46.74 Mn |
| Sep 30, 2011 | -46.74 Mn |
| Jun 30, 2011 | -34.05 Mn |
| Jun 30, 2011 | -34.05 Mn |
| Mar 31, 2011 | -10.58 Mn |
| Mar 31, 2011 | -10.58 Mn |
| Dec 31, 2010 | -40.85 Mn |
| Dec 31, 2010 | -40.85 Mn |
| Sep 30, 2010 | 161.50 Mn |
| Sep 30, 2010 | 161.50 Mn |
| Jun 30, 2010 | -11.85 Mn |
| Jun 30, 2010 | -11.85 Mn |
| Mar 31, 2010 | -9.58 Mn |
| Mar 31, 2010 | -9.58 Mn |
| Dec 31, 2009 | -46.40 Mn |
| Dec 31, 2009 | -46.40 Mn |
| Sep 30, 2009 | -9.82 Mn |
| Sep 30, 2009 | -9.82 Mn |